Completed NA INTERVENTIONAL 1-arm NCT04123119

Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model

Development of a Live Attenuated Rotavirus Vaccine as a Human Infection

Sponsor: Centre for Infectious Disease Research in Zambia

Updated 4 times since 2019 Last updated: Oct 10, 2019 Started: Jan 22, 2019 Primary completion: May 10, 2019 Completion: May 10, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Diarrhoeal Disease and is currently completed. Centre for Infectious Disease Research in Zambia leads this study, which shows 4 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2019 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre for Infectious Disease Research in Zambia
Christian Medical College, Vellore, India
Imperial College London

Data source: Centre for Infectious Disease Research in Zambia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lusaka, Zambia